TripleMed
PrivateLast Round
VC Round
Mar 21, 2024
Total Funding Raised
$2.38M
Company Overview
TripleMed operates in Healthcare & Life Sciences and is based in Geleen. Its latest recorded funding round was a VC Round in March 2024.
TripleMed is a medical device company that develops innovative and cost-effective solutions for the treatment of aortic aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TripleMed Comparables
Compare TripleMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shape Memory Medical | 79% | |
| Endoron Medical | 79% | |
| Taurus Vascular | 71% |
For institutional investors. Book with your work email.
TripleMed Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
TripleMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brightlands Venture Partners | VC Round, Series A |
| LIOF | VC Round, Series A |
TripleMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TripleMed's valuation, stock price, and market status.
Is TripleMed a public or private company?
TripleMed is a private company.
What is the current stock price of TripleMed?
TripleMed is a private company, so its shares have no public market price. Caplight tracks TripleMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TripleMed worth (valuation)?
Valuation information for TripleMed is not publicly available.
Can I buy TripleMed stock?
TripleMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TripleMed's last funding round?
TripleMed's most recent funding round was VC Round on March 21, 2024.
Who are the main investors in TripleMed?
Key investors in TripleMed include Brightlands Venture Partners, LIOF.
Will TripleMed IPO soon?
No public IPO plans have been announced for TripleMed.
How can I track TripleMed secondary market activity?
Caplight tracks bids, offers, and trades in TripleMed's shares on secondary markets.